Balchem Corp Files 8-K for Regulation FD and Exhibits
Ticker: BCPC · Form: 8-K · Filed: Dec 10, 2024 · CIK: 9326
| Field | Detail |
|---|---|
| Company | Balchem CORP (BCPC) |
| Form Type | 8-K |
| Filed Date | Dec 10, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: BCPC
TL;DR
Balchem filed an 8-K, standard procedure, no major news.
AI Summary
On December 9, 2024, Balchem Corporation filed an 8-K report to disclose information regarding Regulation FD and financial statements. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Balchem Corporation is adhering to its reporting obligations with the SEC, ensuring transparency for investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for regulatory compliance and does not disclose any new material events or financial information.
Key Players & Entities
- Balchem Corporation (company) — Registrant
- December 9, 2024 (date) — Date of earliest event reported
- 5 Paragon Drive, Montvale, NJ 07645 (location) — Principal executive offices address
FAQ
What is the primary purpose of this 8-K filing by Balchem Corporation?
The primary purpose of this 8-K filing is to report information related to Regulation FD Disclosure and Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is December 9, 2024.
Where are Balchem Corporation's principal executive offices located?
Balchem Corporation's principal executive offices are located at 5 Paragon Drive, Montvale, NJ 07645.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Does this filing disclose any specific financial results or material events?
No, this filing is a standard 8-K for reporting purposes and does not disclose specific financial results or new material events.
Filing Stats: 417 words · 2 min read · ~1 pages · Grade level 12.6 · Accepted 2024-12-10 16:15:15
Filing Documents
- ef20039817_8k.htm (8-K) — 26KB
- ef20039817_ex99-1.htm (EX-99.1) — 8KB
- image00001.jpg (GRAPHIC) — 4KB
- image00002.jpg (GRAPHIC) — 6KB
- image00003.jpg (GRAPHIC) — 3KB
- 0001140361-24-048915.txt ( ) — 185KB
- bcpc-20241209.xsd (EX-101.SCH) — 4KB
- bcpc-20241209_lab.xml (EX-101.LAB) — 21KB
- bcpc-20241209_pre.xml (EX-101.PRE) — 16KB
- ef20039817_8k_htm.xml (XML) — 4KB
01
Item 7.01 Regulation FD Disclosure. On December 10, 2024, Balchem Corporation (the "Company") issued a press release announcing a dividend declared by the Company's Board of Directors on December 9, 2024. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated December 9, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BALCHEM CORPORATION (Registrant) By: /s/ Hatsuki Miyata Hatsuki Miyata Executive Vice President, General Counsel and Secretary Date: December 10, 2024